Supplementary Data (mouse data) 1 from A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death–Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma
Selecting and designing an optimal animal model is a key component of translational science, though there is often no consensus on which model is optimal for a particular disease. Here, we generated a
